SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's launches generic version of Sapropterin Dihydrochloride Tablets

05 Oct 2020 Evaluate

Dr. Reddy’s Laboratories has launched a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. The company’s Sapropterin Dihydrochloride Tablets, 100 mg are available in bottle count sizes of 120.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1352.60 -4.25 (-0.31%)
01-Jul-2026 09:31 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1875.05
Dr. Reddys Labs. 1352.60
Cipla 1461.50
Zydus Lifesciences 1116.85
Lupin 2430.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: